Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Supratek Pharma Inc.
DescriptionBiotransport nano-composition of block copolymers and doxorubicin
Molecular Target DNA
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today